Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Ephrin Receptor B2 Expression May Be a Prognostic Marker for Patients With Cancer: A Meta-analysis

HYUN MIN KOH, CHANG LIM HYUN, BO GUN JANG and HYUN JU LEE
Anticancer Research August 2020, 40 (8) 4309-4317; DOI: https://doi.org/10.21873/anticanres.14433
HYUN MIN KOH
1Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHANG LIM HYUN
2Department of Pathology, Jeju National University School of Medicine, Jeju, Republic of Korea
3Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BO GUN JANG
2Department of Pathology, Jeju National University School of Medicine, Jeju, Republic of Korea
3Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HYUN JU LEE
4Department of Pathology, Soonchunhyang University College of Medicine, Cheonan, Republic of Korea
5Department of Pathology, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: drlhjmd@daum.net
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Flow diagram of study selection process.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Forest plot for the relationship between ephrin receptor B2 expression and overall survival. CI: Confidence intervaI; HR: hazard ratio.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Forest plot of studies evaluating ephrin receptor B2 expression and overall survival stratified by cancer type. CI: Confidence intervaI; HR: hazard ratio.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Forest plot for the relationship between ephrin receptor B2 expression and disease-free survival. CI: Confidence intervaI; HR: hazard ratio.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Forest plot of studies evaluating ephrin receptor B2 expression and disease-free survival stratified by cancer type. CI: Confidence intervaI; HR: hazard ratio.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Forest plot for the relationship between ephrin receptor B2 expression and clinicopathological variables. (A) tumor grade, (B) tumor stage, (C) lymph node metastasis, and (D) overall stage. CI: Confidence intervaI; OR: odds ratio.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Funnel plot (A, B) and trim and fill method (C, D) for the relationship between ephrin receptor B2 expression and overall survival (A, C) and disease-free survival (B, D) with 95% confidence intervaIs.CI: Confidence intervaI; LnHR: logn hazard ratio; SE: standard error.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Sensitivity analysis for the relationship between ephrin receptor B2 expression and overall survival (A) and with disease-free survival (B). CI: Confidence intervaI.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Anticancer Research: 40 (8)
Anticancer Research
Vol. 40, Issue 8
August 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ephrin Receptor B2 Expression May Be a Prognostic Marker for Patients With Cancer: A Meta-analysis
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Ephrin Receptor B2 Expression May Be a Prognostic Marker for Patients With Cancer: A Meta-analysis
HYUN MIN KOH, CHANG LIM HYUN, BO GUN JANG, HYUN JU LEE
Anticancer Research Aug 2020, 40 (8) 4309-4317; DOI: 10.21873/anticanres.14433

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Ephrin Receptor B2 Expression May Be a Prognostic Marker for Patients With Cancer: A Meta-analysis
HYUN MIN KOH, CHANG LIM HYUN, BO GUN JANG, HYUN JU LEE
Anticancer Research Aug 2020, 40 (8) 4309-4317; DOI: 10.21873/anticanres.14433
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
  • Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study
  • Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
Show more Clinical Studies

Similar Articles

Keywords

  • cancer
  • ephrin receptor B2
  • meta-analysis
  • prognosis
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire